← Back
▲ BUY
10 / 10

Conviction

$ Value

$91K

Shares

10,793

Price

$8

Filed

Nov 19

Why this score? (10/10)
  • Open market buy (+3)
  • % of holdings >= 50% (+3)
  • C-suite insider (+2)
  • Director (+1)
  • 10%+ owner (+1)
  • Cluster: 4 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

ALAM JOHN J

Title

CEO & President

CIK

0001197014

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-11-17

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

12,500

Footnotes

Shares purchased in open-market transactions. | The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range. | Includes (i) 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the John J. Alam Roth IRA. | Shares held by the Sylvie Gregoire Roth IRA. | The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Filing Info

Accession No.

0001437749-25-035652

Form Type

4

Issuer CIK

0001053691

ALAM JOHN J's History

Date Ticker Type Value
2026-02-11 CRVO A $0
2025-11-17 CRVO $91K
2025-11-17 CRVO $91K
2025-11-14 CRVO $13K
2025-11-14 CRVO $13K
2025-11-13 CRVO $33K
2025-11-12 CRVO $41K
2025-06-23 CRVO A $0

Other Insiders at CRVO (90d)

Insider Bought Sold Last
ALAM JOHN J
CEO & President
2026-02-11
Gregoire Sylvie 2026-02-11
Blackburn Kelly
EVP, Clinical Development
2026-02-11
ELDER WILLIAM ROBERT
CFO, GC & Secretary
2026-02-11
De Rosch Mark
EVP, RA and GA and PgM
2026-02-11
Winton Matthew
Chief Commercial and Business
2026-02-11